EHEleanor Hayes-Larson

Eleanor Hayes-Larson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eleanor Hayes-Larson has a total of 176 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Age at Menopause and Dementia Risk: Blood-Based Biomarker Evidence from a US National Study

    by Sirena Gutierrez, Michelle R. Caunca, Muqi Guo, Eleanor Hayes-Larson, Sadaf A. Milani, Paola Gilsanz, Jacqueline M. Torres, Kaitlin B. Casaletto

    Importance: Earlier age at menopause associates with increased later life dementia risk, but the biological links that underlie this relationship remain poorly understood in population-based samples. Objective: To evaluate the relationship between history of menopausal timing and AD/ADRD-related blood-based biomarkers in postmenopausal women. Design: Observational study using the U.S. Health and Retirement Study. AD/ADRD-related biomarkers were measured from venous blood draws conducted in 2016 and released in 2025. We estimated linear and nonlinear associations between spontaneous menopause timing and biomarkers, accounting for sociodemographic and health covariates. We evaluated effect modification by APOE ɛ4 carrier status. Secondary analyses evaluated associations with hysterectomy history. Setting: Population-based. Participants: Community-dwelling post-menopausal women aged 65 years or older. Exposure: Primary: Self-reported spontaneous age of menopause among women with no history of hysterectomy. Secondary: Self-reported history of hysterectomy (oophorectomy history was not assessed). Main Outcomes and Measures: Neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) measured in plasma, and phosphorylated tau (p-tau181) and growth differentiation factor 15 (GDF-15), measured in serum, by Simoa or ELLA. Results: Among 1449 women ≥65 years, 38.4% self-reported a hysterectomy. Among 893 postmenopausal women without a history of hysterectomy (mean [SD] age at biomarker collection, 75.2 [7.2] years; mean age at menopause, 50.2 [5.2] years), menopausal timing was nonlinearly associated with NfL. Between menopausal ages 45-50, menopause timing was associated with higher NfL (0.010 SD units/year, [95% CI: -0.007, 0.027]), while from menopausal ages 50-55, the association reversed (b= -0.031, [95% CI: -0.051, -0.011]). Associations with GFAP or pTau-181 were not significant, but were directionally similar to those observed for NfL. Later menopausal timing linearly associated with lower GDF-15 (b = -0.015, [95% CI: -0.027, -0.004]). Self-reported hysterectomy was associated with higher GDF-15 (b= 0.118, [95% CI: 0.015, 0.220]), but not other biomarkers. Associations did not significantly differ by APOE ϵ4 status. Conclusions and Relevance: In a nationally representative study, earlier age at menopause in midlife was associated with later life AD/ADRDs biomarkers reflecting neuroaxonal degeneration and inflammation, underscoring the importance of understanding reproductive aging in dementia risk.

  • Open Access

    Classification matters: divergent estimates of dementia risk factors in the health and retirement study

    by Gina E Nam, Junxian Liu, Suhani Amin, Karla Renata Flores Romero, Zachary J Kunicki, M Maria Glymour, Kaitlin B Casaletto, Jacqueline M Torres, Eleanor Hayes-Larson

    Clinical dementia diagnosis requires substantial expertise and is complex and costly. Therefore, large population-based studies often lack gold-standard longitudinal diagnoses and instead use classification algorithms employing cognitive, functional, and health-related measures to identify dementia. We evaluated whether algorithm choice affects conclusions regarding dementia risk in the nationally representative Health and Retirement Study (HRS; 2010-2020). We constructed 4 algorithm-specific samples of participants age 70+ without dementia in 2010: Langa-Weir (n = 6498), Hudomiet (n = 6556), Expert (n = 5751), and Wu (n = 5935). Participants were followed until first dementia classification, death, or censoring. We estimated dementia incidence rates (IRs) and used adjusted Cox models to estimate HRs for known risk factors. Dementia IRs per 1000 person-years meaningfully varied across algorithms, from 26.5 (95% CI 24.5-28.5, Hudomiet) to 62.8 (59.9-65.8, Expert). Sociodemographic risk factor associations also varied substantially. HRs for education (< vs ≥high school) ranged from 1.36 (1.19-1.54, Hudomiet) to 2.22 (1.98-2.50, Langa-Weir), and HRs for non-Hispanic Black vs non-Hispanic White ranged from 1.86 (1.53-2.27, Expert) to 2.74 (2.40-3.12, Langa-Weir). Differences were less pronounced for health-related risk factors. In the absence of gold standard longitudinal diagnosis in HRS, researchers should examine the robustness of findings across multiple algorithms.

  • Body mass index and mortality in incident dementia

    by Virginia W. Chang, Eleanor Hayes-Larson, Hui Zheng, Yuan S. Zhang

    Background: Limited evidence suggests that higher body weight may be associated with improved survival among individuals with dementia relative to those in the normal weight range. The mechanisms underlying this association are uncertain and may include both physiological and methodological factors. Objective: To examine the association between weight status at incident dementia and mortality and to assess potential sources of bias. Methods: We examined the association between weight status at incident dementia and mortality in a large, U.S. population-based sample with extended follow-up. We also evaluated potential sources of bias affecting this association, including confounding due to weight loss, collider stratification bias, and survivor bias. Results: Compared with the normal weight category, class I obesity at incident dementia was associated with a 27% lower risk of mortality (HR 0.73, 95% CI: 0.62–0.86). Overweight and class II/III obesity were also associated with lower mortality. Analyses evaluating potential sources of bias did not support these mechanisms as major contributors to the observed associations. Conclusions: In a large, U.S. population-based sample with extended follow-up, overweight and obesity at incident dementia were associated with lower mortality relative to normal weight. While the underlying mechanisms are not fully understood, these findings suggest that weight status at diagnosis may serve as a useful prognostic indicator alongside other factors.

  • Open Access

    Stress sensitization: Does childhood adversity modify trauma effects on memory?

    by Gina E. Nam, Junxian Liu, Mary Thoma, Lindsay C. Kobayashi, Karestan C. Koenen, Zachary J. Kunicki, Eleanor Hayes-Larson

    Background: Trauma across the lifecourse is implicated in adverse health outcomes, yet whether earlier adversity shapes vulnerability to effects of later trauma on cognitive decline, an important contributor to Alzheimer's disease, remains unclear. Objective: We examined the impact of adult incident traumatic experiences (ITEs) on late-life memory decline, and whether this association is modified by childhood adversity. Methods: We leveraged 2006–2020 data from the Health and Retirement Study, a longitudinal cohort of US adults aged ≥50 years. ITEs were self-reported stressful or life-threatening experiences in 2006–2012 (any versus none). Childhood adversity (any versus none) included retrospective reports of abuse, neglect, or household dysfunction before age 18. Memory was assessed biennially from 2010–2020 using standardized scores. Linear mixed-effects models estimated associations between ITEs and decline in memory z-score, adjusted for demographics, childhood socioeconomic status, and self-rated health. Stratified analyses examined effect modification by childhood adversity. Results: Among 2971 participants, mean baseline age was 67.3 years (SD 9.2); 60% were female and 86% were White. Individuals with ITEs experienced a faster memory decline than those without ITEs (β= −0.014 SD units/year, 95% CI −0.024, −0.003). Childhood adversity did not modify this association. Findings were consistent across sensitivity analyses using alternative exposure and outcome definitions. Conclusions: ITEs were associated with accelerated memory decline in later life, and childhood adversity did not modify this relationship. Identifying resilience factors that mitigate the cognitive effects of adult traumatic experiences may inform prevention strategies for Alzheimer's disease.

  • Open Access

    Validation of clinical diagnosis and machine learning classification of cognitive impairment

    by Dan Mungas, Evan Fletcher, Keith Widaman, Sarah Tomaszewski Farias, Shraddha Sapkota, Pauline Maillard, Eleanor Hayes-Larson, L. Paloma Rojas-Saunero, Yixuan Zhou, Crystal Shaw, et al.

    Structured INTRODUCTION: Cognitive syndrome diagnosis (Normal, Mild Cognitive Impairment (MCI), Dementia) is important for summarizing disease status and predicting future progression. Machine learning approaches to classification might substitute for or complement clinical diagnosis but must be shown to have validity for these purposes. METHODS: A machine learning algorithm was trained in a previous study to reproduce clinical diagnosis of cognitive impairment [1]. We examined and compared concurrent validity (cross-sectional MRI measures of brain integrity) and predictive validity (longitudinal change in MRI measures of brain integrity and progression to a more impaired diagnosis/classification) of clinical diagnosis and algorithmic classification from the prior study. RESULTS: Clinical diagnosis and algorithmic classifications had robust associations with clinical and MRI outcomes and differences across diagnosis/classification types were minor. Algorithmically estimated probability of a Normal diagnosis had the strongest associations with cross-sectional and longitudinal MRI outcomes. Progression from Normal to MCI or Dementia was faster for Clinical diagnosis than Algorithmic classification but future rates of MRI measured brain degeneration were essentially the same in individuals with baseline clinical diagnosis and algorithmic classification of Normal cognition. DISCUSSION: Clinical diagnosis and algorithmic, machine learning based classification had robust and similar associations with independent validity criteria. Both forms of diagnosis/classification had utility for staging current brain degeneration and predicting future brain degeneration and clinical decline. This study demonstrates a validation design that can simultaneously evaluate the utility of both clinical diagnosis and algorithmic classification of cognitive impairment in a manner that improves understanding of both types of classification.

  • Hypertension and 10-Year Dementia Risk Among Older Asian American and Non-Latino White Adults in Northern California

    by L. Paloma Rojas-Saunero, Natalie Gradwohl, Joseph O. Fong, Yixuan Zhou, Yingyan Wu, Taylor M. Mobley, Eleanor Hayes-Larson, Roch A. Nianogo, Gilbert C. Gee, Ron Brookmeyer, et al.

    Introduction: Hypertension is a modifiable risk factor for dementia, but its contribution among Asian American ethnic groups remains understudied despite heterogeneity in cardiovascular risk factors. Methods: Participants were Kaiser Permanente Northern California members aged 60 to 90 years without prevalent dementia at baseline, surveyed between 2002 and 2009 [Chinese (n=4,848), Filipino (n=4,130), Japanese (n=2,786), South Asian (n=823), non-Latino White (n=123,593)]. We used ICD-codes to identify hypertension (assessed 5 y before baseline) and incident dementia through 2020. Within strata of race/ethnicity and baseline age group (60 to 75 and 75 to 90 y), we estimated adjusted and standardized 10-year dementia risk, risk ratios, risk differences, and population attributable fractions (PAFs) using pooled logistic regression, treating death as a censoring event. Results: Among Chinese, Filipino, Japanese, and non-Latino White participants aged 60 to 75 years, PAFs (95% CI) were 12% (−3% to 28%), 23% (4% to 40%), 9% (−7% to 27%), and 8% (5% to 10%), respectively. Effect estimates were null for these groups among participants aged 75 to 90. For South Asian participants, point estimates were consistent with protective associations among those aged 60 to 75 and harmful associations among those aged 75 to 90, although estimates were imprecise. Conclusion: Our findings suggest heterogeneity in the effect of hypertension on dementia risk across Asian American ethnic groups and by age.

  • Open Access

    Relative and absolute exposures in multi-site and multi-cohort research

    by Emma Nichols, Mateo P Farina, Emma L Gause, Alden L Gross, Eleanor Hayes-Larson, Birgit Claus Henn, Kayleigh P Keller, Katrina L Kezios, David Knapp, Erik Meijer, et al.

    Pooling data across study sites or studies can provide opportunities to answer novel research questions, especially when exposure distributions vary across settings. The decision to use absolute (ie, on a common metric across studies) vs relative (ie, scaled within each contributing study) exposure measures is an underappreciated but important decision point, and is relevant across heterogeneous exposure domains and disciplines. The use of absolute vs relative exposure measures can impact construct validity, study results, and the interpretation of findings. We highlight 3 key considerations that should drive decision-making: (1) conceptual and hypothesis-related factors (ie, construct validity), (2) confounding by place, and (3) harmonization. We argue that construct validity should be prioritized above other factors, though challenges around confounding by place and considerations related to the comparability of exposure measures across surveys may also influence decision-making. To help readers understand how these considerations may apply practically, we discuss 2 example associations (educational attainment and cognition, heat and mortality) that illustrate implications related to the choice of absolute vs relative exposure measures. We highlight key considerations and provide recommendations to researchers to aid decision-making and increase the quality and transparency of research.

  • Open Access

    Substituting blood-based biomarkers for imaging measures in Alzheimer’s disease studies: implications for sample size and bias

    by Sarah F Ackley, Renaud La Joie, Michelle Caunca, Shubhabrata Mukherjee, Seo-Eun Choi, Emily H Trittschuh, Paul K Crane, Eleanor Hayes-Larson, For The Alzheimer’S Disease Neuroimaging Initiative

    Background: Blood-based biomarkers for Alzheimer’s disease (AD) pathology are appealing options in large population-based studies due to their low cost, minimal invasiveness, and feasibility of collection in non-clinical settings. Despite these benefits, blood-based biomarkers have lower test-retest reliability than neuroimaging measures like amyloid positron emission tomography (amyloid-PET) Centiloids; trade-offs in power and bias remain unexplored. Methods: We use data from Alzheimer’s Disease Neuroimaging Initiative (ADNI) and the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) studies, which include both amyloid-PET and blood-based measures, to assess differences in statistical power, required sample size, and bias when replacing a neuroimaging measure with a blood-based measure. We use simulations parameterized based on these studies to show potential implications of using plasma p-tau 181 or p-tau 217, blood-based AD biomarkers, in place of Centiloids from amyloid-PET, when the biomarker is either the exposure or the outcome in an analysis of interest. Results: We demonstrated that substituting amyloid-PET Centiloids with a blood-based measure of p-tau can substantially reduce power, requiring 1.5-6.5 times the sample size to achieve 80% power compared to amyloid-PET. In addition, using a blood-based biomarker as the exposure can introduce significant regression dilution bias, attenuating estimated associations. Conclusions: While blood-based biomarkers are lower cost and easier to collect than neuroimaging measures, their use as proxies for AD pathology may introduce substantial methodological challenges, depending on the p-tau isoform. Consideration of the sample sizes they necessitate and their potential for bias is critical for the design and interpretation of studies employing these biomarkers.


  • Social isolation and functional impairment trajectories in a diverse cohort of middle-aged and older adults in Northern California

    by L Paloma Rojas-Saunero, Ryo Ikesu, Yixuan Zhou, Eleanor Hayes-Larson, Joseph Oliver Fong, Ruijia Chen, Alexander Ivan B Posis, Rachel A Whitmer, Paola Gilsanz, M Maria Glymour, et al.

    Background: Social isolation is a key social determinant of health, yet research on its relationship with functional impairment is limited. We compared functional impairment score trajectories of older adults who experienced social isolation versus those who did not, using 2 different statistical approaches to handle attrition due to dropout and death. Methods: Data were from 2 Northern California observational cohorts of people aged 50+ (n = 2476): Kaiser Healthy Aging and Different Life Experiences (KHANDLE) and Study of Healthy Aging in African Americans (STAR). We fit linear mixed effects models for functional impairment scores (sum of 12 items measuring basic activities of daily living [ADLs], instrumental ADLs, and mobility; range: 0-36) by baseline social isolation status (yes/no; 3-5 positive answers on 5 social contact items), adjusted for age and sex/gender. We estimated average marginal wave-specific differences in functional impairment scores, comparing approaches to address attrition. Results: At baseline, 30% of participants reported social isolation; the median functional impairment score was 2 (Q1, Q3 = 0, 5). Baseline functional impairment scores were 1.03 points (95% CI, 0.84-1.20) higher among participants experiencing social isolation versus not. At wave 4, this difference decreased to 0.80 (95% CI, 0.52-1.07) among those remaining in the study and increased to 1.16 (95% CI, 0.83-1.42) assuming attrition was eliminated. Dropout and death were higher among participants experiencing social isolation. Conclusion: In a diverse cohort of older adults, those experiencing social isolation tend to experience greater functional impairment, but differences in trajectories depend on how attrition is handled.